awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q39039468-1CA88C13-580A-4973-B315-23EF94554361
Q39039468-1CA88C13-580A-4973-B315-23EF94554361
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39039468-1CA88C13-580A-4973-B315-23EF94554361
Is there a need to increase the dose of efavirenz during concomitant rifampicin-based antituberculosis therapy in sub-Saharan Africa? The HIV-TB pharmagene study.
P2860
Q39039468-1CA88C13-580A-4973-B315-23EF94554361
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39039468-1CA88C13-580A-4973-B315-23EF94554361
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4e13cd8867bda4c4a3dc0858221e628841fe7f80
P2860
Efavirenz primary and secondary metabolism in vitro and in vivo: identification of novel metabolic pathways and cytochrome P450 2A6 as the principal catalyst of efavirenz 7-hydroxylation